Ruth Lorna Mary Cordiner (Ruth L M Cordiner, Ruth Lm Cordiner)

Years Active: 2019-2024
Publications (10 Years): 6

Southern General Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Southern General Hospital Aug 07 2013

United Kingdom

CMT1 :: Medicine

Beatson West of Scotland Cancer Centre

United Kingdom

FY2 :: Oncology

Western Infirmary

United Kingdom

FY2 :: Trauma and Orthopaedic Surgery

Western Infirmary

United Kingdom

FY2 :: General Surgery

Gartnavel General Hospital

United Kingdom

FY1 :: General Medicine

Gartnavel General Hospital

United Kingdom

FY1 :: Respiratory Medicine

Western Infirmary

United Kingdom

FY1 :: Vascular/General Surgery

Publications

Ruth Lorna Mary Cordiner, Khaled Bedair, Andrea Mari, Ewan R Pearson
Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia. The Journal of clinical endocrinology and metabolism 109 (8) (2024)
Ruth Lorna Mary Cordiner, Khaled Bedair, Andrea Mari, Ewan R Pearson
Low dose sulphonylurea plus DPP4 inhibitor lower blood glucose and enhance beta cell function without hypoglycaemia. The Journal of clinical endocrinology and metabolism (2024)
Ruth Lorna Mary Cordiner, Khaled Bedair, Andrea Mari, Ewan R Pearson
Low-Dose Sulfonylurea Plus DPP4 Inhibitor Lower Blood Glucose and Enhance Beta-Cell Function Without Hypoglycemia. The Journal of clinical endocrinology and metabolism 109 (8) (2024)
Ruth Lorna Mary Cordiner, Andrea Mari, Andrea Tura, Ewan R Pearson
The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function. The Journal of clinical endocrinology and metabolism 106 (7) (2021)
Ruairidh Nicoll, Mark White, Luis Loureiro Harrison, Ruth Lorna Mary Cordiner, Malcolm Daniel, Brian Choo-Kang, James G Boyle
Improving the quality of weekend medical handover on non-receiving medical hospital wards. BMJ open quality 10 (4) (2021)
Ruth Lorna Mary Cordiner, Ewan R Pearson
Reflections on the sulphonylurea story: A drug class at risk of extinction or a drug class worth reviving? Diabetes, obesity & metabolism 21 (4) (2019)

Ruth Lorna Mary Cordiner.css-eqlu8i{font-size:small;padding-left:4px;} (Ruth L M Cordiner, Ruth Lm Cordiner)